Cypress Capital Group Sells 8,885 Shares of Cardinal Health, Inc. (NYSE:CAH)

Cypress Capital Group trimmed its holdings in Cardinal Health, Inc. (NYSE:CAH) by 74.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,984 shares of the company’s stock after selling 8,885 shares during the quarter. Cypress Capital Group’s holdings in Cardinal Health were worth $411,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. JPMorgan Chase & Co. raised its holdings in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares during the last quarter. Marshall Wace LLP raised its holdings in Cardinal Health by 154.6% during the 4th quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock worth $372,756,000 after purchasing an additional 1,913,892 shares during the last quarter. Northern Trust Corp raised its holdings in Cardinal Health by 16.2% during the 4th quarter. Northern Trust Corp now owns 3,037,849 shares of the company’s stock worth $359,286,000 after purchasing an additional 422,755 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Cardinal Health by 4.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company’s stock worth $274,599,000 after purchasing an additional 94,768 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its holdings in Cardinal Health by 3.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,601,322 shares of the company’s stock worth $189,390,000 after purchasing an additional 55,781 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Performance

NYSE CAH opened at $158.07 on Tuesday. The business has a 50 day simple moving average of $160.10 and a 200 day simple moving average of $144.16. Cardinal Health, Inc. has a 52-week low of $100.07 and a 52-week high of $168.44. The stock has a market cap of $37.73 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 1.56 and a beta of 0.67.

Analyst Ratings Changes

Several analysts have weighed in on the company. Evercore ISI reissued an “outperform” rating and set a $180.00 price objective (up from $175.00) on shares of Cardinal Health in a report on Thursday, June 12th. Citigroup reissued a “neutral” rating and set a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Robert W. Baird boosted their price objective on Cardinal Health from $156.00 to $170.00 and gave the stock an “outperform” rating in a report on Friday, May 2nd. Wells Fargo & Company raised Cardinal Health from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $136.00 to $179.00 in a report on Tuesday, June 3rd. Finally, Bank of America boosted their price objective on Cardinal Health from $165.00 to $170.00 and gave the stock a “buy” rating in a report on Tuesday, June 10th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $158.07.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.